Current studies focusing on these novel amino acid sequences, a unique type of agents exhibiting remarkable capability for targeting multiple disease processes. Compared to traditional small molecule techniques, these amino acid sequences present enhanced targeting and lesser unintended reactions, enabling them a truly encouraging avenue for future